Medroxyprogesterone acetate as a contraceptive.
D000328:Adult; D001706:Biopsy; D001780:Blood Coagulation Tests; D001831:Body Temperature / Q000187:drug effects; D002584:Cervix Uteri / Q000166:cytology / Q000473:pathology; D003692:Delayed-Action Preparations; D003718:Denmark; D004717:Endometrium / Q000473:pathology; D005260:Female; D005306:Fertilization / Q000187:drug effects*; D006065:Gonadotropins, Pituitary / Q000652:urine; D006801:Humans; D007273:Injections, Intramuscular; D008111:Liver Function Tests; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009092:Mucous Membrane / Q000166:cytology; D010053:Ovary / Q000033:anatomy & histology; D010298:Parity; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D014621:Vagina / Q000166:cytology
D003692:Delayed-Action Preparations; D006065:Gonadotropins, Pituitary; D008525:Medroxyprogesterone; D011276:Pregnanediol